Tu Salud

Tu Salud stands out as the top health magazine for Latinos in the United States. Since its inception in 2007, it has focused on fitness, nutrition, and various health concerns that impact Latino families. The magazine is widely available across the country, reaching readers through doctors’ offices, health clinics, and community organizations.

National, Hispanic/Latine

English, Spanish

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#8669227

United States

#3010717

Articles

Gender-Affirming Care May Lead to Better HIV Outcomes for Trans People

2 weeks ago | tusaludmag.com | Liz Highleyman

Transgender people who receive gender-affirming hormone therapy appear to have better HIV outcomes, according to a new study published in The Lancet HIV. As the proportion of trans and gender-diverse people receiving hormone therapy rose at two primary care clinics, HIV prevalence and the likelihood of not having viral suppression declined. “Gender-affirming care is important for optimizing HIV outcomes among trans people,” the study authors concluded.
CDC Updates Post-Exposure Prophylaxis Guidelines

1 month ago | tusaludmag.com | Liz Highleyman

In a long-awaited update, the Centers for Disease Control and Prevention (CDC) issued new guidelines for HIV post-exposure prophylaxis (PEP) on May 6. The new guidance—the first revision since 2016—now includes more modern antiretrovirals taken for a month after non-occupational exposure, such as sex or injection drug use.
Cooling or Compressing Hands During Chemo Can Prevent Neuropathy

1 month ago | tusaludmag.com | Liz Highleyman

Women who wear frozen or tight-fitting gloves during taxane-based chemotherapy for breast cancer are less likely to develop painful peripheral neuropathy, according to research published in JAMA Oncology. While both methods were effective, compression is more accessible and may be better tolerated than cold temperature. Cytotoxic chemotherapy is an effective treatment for many types of cancer, but the medications can harm or kill normal cells along with malignant cells, leading to side effects.
NIH Grant Cuts Threaten Progress in HIV Prevention and Treatment

1 month ago | tusaludmag.com | Liz Highleyman

The Trump administration has rescinded hundreds of National Institutes of Health (NIH) research grants, including many that involve HIV and sexually transmitted infections (STIs). Scientists and advocates have filed a lawsuit to stop the cuts, but prospects for continued funding remain uncertain.
Broadly Neutralizing Antibodies Show Promise for Long-Acting HIV Treatment

2 months ago | tusaludmag.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) may work well with lenacapavir or cabotegravir in long-acting regimens for HIV treatment, according to two presentations this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in San Francisco. One study showed that teropavimab and zinlirvimab, two bnAbs from Gilead Sciences, worked well in combination with twice-yearly lenacapavir (Sunlenca).
Is RFK Jr. Behind a Crackdown on Poppers?

2 months ago | tusaludmag.com | Liz Highleyman

At least one major seller of poppers has been raided by the Food and Drug Administration (FDA) and other brands shut down their websites and social media last week, according to a report from Fast Company. Some suspect the directive may have come from newly appointed health secretary Robert F. Kennedy Jr., who has suggested that poppers cause AIDS.
Two More People May Be Cured of HIV After Stem Cell Transplants

2 months ago | tusaludmag.com | Liz Highleyman

Two more people appear to be free of HIV after stem cell transplants for cancer treatment, according to a pair of posters presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) this week in San Francisco. If the men remain in remission, they will be the eighth and ninth cases of a functional cure after the procedure.
Triple Antibody Cocktail Delays HIV Rebound After Antiretrovirals

Feb 19, 2025 | tusaludmag.com | Liz Highleyman

A combination of three broadly neutralizing antibodies (bnAbs) may maintain viral suppression for several months after stopping antiretroviral treatment, according to a small study published in Nature Medicine. This approach is risky, however, for people with antibody-resistance virus.
Personalized Vaccine May Help Prevent Kidney Cancer Recurrence

Feb 15, 2025 | tusaludmag.com | Liz Highleyman

A customized kidney cancer vaccine made from patients’ tumors was well tolerated and appeared promising in a small study, according to findings published in Nature. These early findings add to the growing evidence that therapeutic vaccines could play a role in controlling cancer. “The idea behind this trial was to specifically steer the immune system toward a target that is unique to the tumor,” David Braun, MD, PhD, of Yale Cancer Center, said in a news release.
New Jersey’s Hyacinth AIDS Foundation Celebrates 39 Years of HIV Service

Nov 5, 2024 | tusaludmag.com | Trenton Straube

Fierce poses were struck and HIV advocates were honored at Hyacinth AIDS Foundation’s 39th gala and silent auction November 2 at the Newark Museum of Art in New Jersey. Hyacinth has been providing HIV services and advocacy in the Garden State since 1985 and currently operates in seven regional offices. The evening of celebration and dance also honored individuals making a difference and inspiring others.